Special Issue "Pre-Clinical Marine Drug Discovery"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (17 May 2019) | Viewed by 43765
Interests: diabetes; obesity; cancer; non-communicalbe diseases; marine natural compounds; fucoidan; seaweed; clams; food chemistry; pharmacology; drug metabolism; pharmacokinetics; pre-clinical pharmacology; natural compound extraction; polyamine metabolism; marine bioactives
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biomedicines: Biomedicine from the Sea
Special Issue in Marine Drugs: Pre-clinical Marine Drug Discovery Ⅱ
Special Issue in Biomedicines: Feature Papers in Drug Discovery and Development
Special Issue in Biomolecules: Advances in Cell and Immunotherapeutic Approaches to Diabetes
Topical Collection in Biomedicines: Feature Papers in Drug Discovery
Special Issue in Biomedicines: Biomedicines From the Sea, Volume II
Special Issue in Biomedicines: Feature Reviews in Drug Discovery
Special Issue in Biomedicines: Selected Papers in the 2nd International Electronic Conference on Biomedicines (ECB 2023)
Marine products provide ample opportunities for us to find bioactive compounds. To identify and confirm their bioactivities, pre-clinical studies are necessary before they can be developed further, either as health products or ultimately as medicine. There are plenty of pre-clinical tools and models for marine drug discovery. Through pre-clinical screening, many marine compounds have demonstrated important biological properties in the prevention and treatment of various diseases, including cancer, neurodegenerative diseases, obesity, diabetes, etc. Pre-clinical screening is a crucial step for discovering new lead compounds from marine products, therefore, this "Pre-Clinical Marine Drugs Discovery” Special Issue aims to gather the most relevant and new research articles in the field. We hope to capture the progress and development in this important field. It is also a chance for scientists who are working on pre-clinical marine drug discovery to showcase their recent findings and attract the attention of marine drug developers.
Assoc. Prof. Jun Lu
Assoc. Prof. Yu Zhao
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine products
- natural compounds
- pre-clinical screening
- mechanism of action
- extraction and analysis
- bioactive extracts and fractions
- pre-clinical models
- pre-clinical pharmacology
- molecular target